CONTACT INFORMATION€¦ · 9) Stanchina M, Malhotra A, Fogel RB, Ayas NT, Edwards JK, Schory K,...

Grant ID: 17776Applicant: Kate Tester

Host Institution: MSFHR-DO NOT USECompetition: 2018 Implementation Science Team - DO NOT APPLY, TESTING ONLY

Task: Development Grant Letter of Intent (IST)Submitted:

1 | P a g e

CONTACT INFORMATION

Name Ms. Kate Tester

Organization Affiliations

MSFHR-DO NOT USE

E-mail Address [email protected]

Address#200 - 1285 W Broadway #200 - 1285 W Broadway

Vancouver, BC V6H 3X8

Phone 604-714-2777 Ext.

Degrees , , ,

Web Address

Health Professional No - N/A




2 | P a g e

HOST INSTITUTION

Host Institution

Primary Role Organization City Country

Yes Host Institution MSFHR-DO NOT USE Vancouver Canada

Research Location

Role Organization City Country

Research Location MSFHR-DO NOT USE Vancouver Canada




3 | P a g e

PROJECT INFORMATION

Project Title Project Title

Brief Description Please enter a short description of the proposed implementation science study, identifying the key question or health issue to be addressed and health intervention to be implemented, and highlighting key outcomes you hope to achieve. The brief description will guide MSFHR staff in the facilitation of the peer review process and provide reviewers with an overview of your proposed work.

Character limit: 5000




4 | P a g e

KEYWORDS

Keywords Rural Health, Nursing Education, Health Services Delivery, Health Promotion, Community Health/Public Health




5 | P a g e

THIRD PARTY

Applicant

Primary Role Name Organization Name

Yes Principal Kate Tester, MSFHR-DO NOT USE

Third Party

Role Name Organization Name

Department Head August Tester, MSFHR-DO NOT USE

Research User Co-Lead January Tester, MSFHR-DO NOT USE

Researcher Co-Lead February Tester, MSFHR-DO NOT USE




6 | P a g e

ADDITIONAL INFORMATION

Team Description (IST)

1. List all additional team members involved in the planning and execution of the proposed work beyond the other co-leads, including each member's:

a) Name and position

b) Organization affiliation

c) Designation as a researcher or research user.

2. Specify each team member's role and areas of expertise so as to demonstrate that the team composition is appropriate within the context of the proposed implementation science study and includes the relevant expertise for the work to be undertaken.

a) Describe the team's individual and collective experience with aspects of the proposed implementation science study, i.e. the setting(s), intervention, and/or implementation process.

b) Identify any key gaps in the composition of the team, explain how you intend to fill them and when you intend to fill them.


Team Governance and Management

Provide a preliminary overview of your team's plan for its governance and management during the project.


Relevance and Potential Impact

1. Describe how the proposed project is directly relevant to the objectives of this funding




7 | P a g e

opportunity.

2. Describe the rationale for pursuing the questions or issues that are being addressed in this proposed research, including the health care or quality gap being addressed and the potential impactof the proposed research project.

3. Please explain the relevance of the proposed project to the mission, strategic goals and/or priorities of the community, health setting or region of focus.


Training and Mentorship

Provide a preliminary overview of your team's plan for training and mentorship of team members, including how the trainee(s) will be given the opportunity to build their expertise in implementation science through participation in the team.


Use of Development Grant Funds

Outline the plans for use of the Development Grant funds, including in-person meetings, acquisition of preliminary data and other research evidence, stakeholder engagement, etc., so as to advance thedevelopment of the letter of intent towards the full application. Be sure to address:

1. How the Development Grant funds will be used to further the development of the team

2. How the Development Grant funds will be used to further the development of the proposed project

How did you find out about this Program?

Please describe how you found out about the Implementation Science Team program.

Are you within 5 years of your terminal research degree (e.g., MSc, PhD, etc.)?

Are you within 5 years of your terminal research degree? Please indicate yes or no.




8 | P a g e

Reviewers to whom your application should not be sent

Please indicate names and organizational affiliations of anyone to whom your application should not be sent for review.




9 | P a g e

BC HEALTH SYSTEM PRIORITIES (IST)

Is your current program of research related to any of the following BC health system priority areas?

1. Primary and community care Primary

2. Services for patients with complex medical conditions and/or frail patients (including dementia)

Secondary

3. Mental health and/or substance use NotRelated

4. Surgical services (including perioperative services)

Secondary

5. Rural and remote health care services Primary

Is your current program of research related to Indigenous health?

Indigenous health (including First Nations health) NotRelated

Briefly explain the relevance of the proposed project to the BC Health System Priorities.

Briefly explain the relevance of the proposed project to the BC Health System Priorities.

UPLOADS

The following pages contain the uploads provided by the applicant:

Upload Type File Name Uploaded By Uploaded Date

MSFHR Abbreviated CCV

MSFHR Abbreviated CCV.pdf Wilczak, Kate 02/02/2018

Pubs, Patents & Intellectual Rights

Pubs, Patents & Intellectual Rights.pdf

Wilczak, Kate 02/02/2018

Budget IST 2018 IST Budget Template.pdf Wilczak, Kate 02/02/2018

Research Approach Research Approach.pdf Wilczak, Kate 02/02/2018

Ms. Dainty Sales

1

Protected when completed

Date Submitted: 2013-11-08 16:32:11Confirmation Number: 171612Template: Career Annual Report CV

Personal InformationIdentification

Ms. Dainty SalesCorrespondence language: EnglishSex: FemaleDate of Birth: 1/28Canadian Residency Status: Canadian Citizen

AddressThe primary address is denoted by (*)

Primary Affiliation (*)

Michael Smith Foundation forHealth Research1285 West BroadwayVancouverV6H 3X8Canada, British Columbia

TelephoneThe primary telephone is denoted by (*)

Fax 1-604-555-1234

(*) 1-604-7146601

EmailThe primary email is denoted by (*)

(*) [email protected]

User ProfileResearcher Status: ResearcherResearch Career Start Date: 2000-12-12Engaged in Clinical Research?: No

SAMPLE M

SFHR CCV

Ms. Dainty Sales

2

Employment

Leaves of Absence and Impact on ResearchAdministrative

Research Funding History

* - Scholarship

Activities

Assessment and Review Activities

Journal Review Activities*

Conference Review Activities*

Community and Volunteer Activities*

Knowledge and Technology Translation*

International Collaboration Activities*

Memberships

Committee MembershipsChair

Other Memberships*

Contributions

Presentations"*",

SAMPLE M

SFHR CCV

Ms. Dainty Sales

3

Publications

PubMed ArticlesPubMed ID: *

Journal Articles"*",

Journal Issues"*",

Books"*",

Book Chapters"*",

Book Reviews"*",

Translations"*",

Dissertations"*"

Supervised Student Publications*, ,

Litigations"*",

Newspaper Articles"*",

Newsletter Articles"*",

Encyclopedia Entries"*",

Magazine Entries"*",

SAMPLE M

SFHR CCV

Ms. Dainty Sales

4

Dictionary Entries"*",

Reports"*"

Working Papers"*"

Manuals"*",

Online Resources"*"

Tests"*"

Clinical Care Guidelines"*"

Conference PublicationsPaper ,,

Intellectual Property

Patents*,

Licenses*

Disclosures*

Registered Copyrights*

Trademarks*

SAMPLE M

SFHR CCV

Publication List

Abstracts:ffi'"fiT, FitzGerald JM, Fox N, Ryan cF, Marra c, Koehoorn M, Jung D,

chambers K, Fleetham J. Work Productivity and occup-ational tniuries in Patients

with Obstruct¡vi Steep Apnea Hypopnea. Submitted, ATS meeting 2004'

2) Patel sR, white DP, Malhotra A, Stanchina M, Ayas NT. Ihe Effect of 2PAP

Therapy on Suø¡áciivà and Obiective S/eeprness in Oø9t1t19tiu^e-S-leep Apnea: A

M et a- a'n a ty s¡ s íf R a n d o m i ze d' C o ntrotl e d T ri at s' S leep 2002', 25 : A 1 8'

3) Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Ma|hotra A, Hu F. A

prospective stuly of Steep Duration and Coronary Heart Drsease in Women' Sleep

2002',25:A1Q7 .

4) Tachibana N, Ayas NT, White DI A Comparison of Sleep Laboratory Activity in the

lJnited Sfafes and Japan Sleep 20Q2;25:A47 '

5) Pittman sD, Pillar G, Ayas NT, Suraiya s, Malhotra.A,.White DP' Can Obstructive

s/eep Apnea øe oiagnosed in the Home lJsing a wrist-mounted Device with

Automated Anatysis-of Peripherat Arteriat Tonometry, Pulse oximetry, and

ActigraPhY? SleeP 2OO2', 25 -A42'

6) Stanchina M, Malhotra A, Fogel RB, Ayas NT, Edwards JK, Schory K, White DP'

The tnftuenr" oi Cnunging Litng Votlume on Genioglossus Muscle Activation andpharyngeal Mechanics Ouring Ñnef¿ S/eep. Sleep 2002;25:A135.

7) Sutherland ER, Allmers H, Ayas N, Venn AJ, Zello-s-L' Martin RJ' lnhaled

Corficosteroids tmprove The-Accelerated Dectine Of Fevt tn Patients W¡th COPD - A

Meta-Anatysis of b Triats. Am J Respir Crit Care Med 2002',165:A225'

8) MalhotraA, Lazic sE, Fogel RB, Stanchina M, Ayas N, White DP. Sfrucfural And

Functional Differences tn-The Llpper Airway Between Premenopausal And

Postmenopausalwomen. Am J Respir crit care Med 2002; 165:4799'

9) Stanchina M, Malhotra A, Fogel RB, Ayas NT, Edwards JK, Schory K, White DP'

The tnftuence of Changing Lltng Voilume on Genioglossus Muscle Activation andpharyngeat Coi6p,s¡i¡iít."Ourin-g NREM S/eep. Am J Respir Crit Care Med 2002''

165:439.

10)Ayas NT, Nuqent E, Mathew J, Epstein LJ, Malhotra A, White DP' Predictors of'

S]ø¡ective ofiinte S/eeprness in a Sleep Ctinic Poputation Am J Respir Crit Care

Med 2002; 165:4510.

11) Ayas NT, Pittman SD, Malhotra A, Pil lar G, Stanchina M, Winkelman J, White DP'prediction of Daytime S/eeprness using lndices of Autonomic Arousal. Am J Respir

Crit Care Med 2002; 165:4231.

12)Patel SR, Ayas N, Hess D, Kacmarek R, Thompson BT, Wain J, Malhotra A' The

Ut;t;ty of Open Lung Biopsy in Patients with the Acute Respiratory Disfress

SAMPLE P

UBS, PATENTS, &

INTELL

ECUTAL RIG

HTS

2018 Implementation Science Team Development Grant - Budget

A. Human Resources Amount Requested

From MSFHR Justification Requested or received from other sources (specify source)

Example:

Honorarium for guest speaker(s) (up

to $500 CDN per speaker)

TOTAL Human Resources -$

B. Services and Supplies Amount Requested


TOTAL Services and Supplies -$

C. Travel and Sustenance Amount Requested


TOTAL Travel -$

D. Other

(specify)

Amount Requested


TOTAL Other -$

Tax

TOTAL REQUESTED FROM MSFHR -$

BUDGET • List details on costs for all human resources, services and supplies, travel and sustenance, and other eligible expenses. The budget should include appropriate tax.

• The total budget must NOT exceed $10,000. Please review Appendix A in the 2018 Implementation Science Team Competition Guidelines for a list of eligible and ineligible expenses.

• If resources from other sources will be used to complement specific expenses funded by the Development Grant (e.g., in-kind or cash contributions), please list them in the last column (Requested or received

from other sources).

• To add more lines, please insert rows in the respective categories.

Note: Expenses already funded by another grant (MSFHR-funded or otherwise) cannot be deferred to an MSFHR Implementation Science Team Development Grant.

Page 1 2018 Implementation Science Team Development Grant Budget Template.xlsx

Implementation Science Team – Development Grant

RESEARCH APPROACH 4 pages max., not including appendices and references

Provide a summary of the proposed implementation science project. Be sure to include the following:

a. The proposed project's research question(s) and objectives

b. An overview of the proposed implementation science research design and methodologies

c. A description of the intervention being implemented, and overview of evidence for its use

(including references to any relevant systematic reviews or meta-analyses, if applicable)

d. A description of the setting(s) in which the intervention will be implemented

e. An overview of stakeholders to be engaged, including a description of how they will be

involved in the project

f. An assessment of the feasibility of the project and a project timeline

CONTACT INFORMATION€¦ · 9) Stanchina M, Malhotra A, Fogel RB, Ayas NT, Edwards JK, Schory K,...

Documents

Transcript of CONTACT INFORMATION€¦ · 9) Stanchina M, Malhotra A, Fogel RB, Ayas NT, Edwards JK, Schory K,...